The assessment made available on the Mars Labs website does not create a doctor-patient relationship between the individual completing the assessment and Mars Labs. Bundl Financial Technologies Inc, a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the Mars Labs assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and a Bundl Financial Technologies Inc clinician will meet with an individual after checkout to determine if they qualify for a prescription. Bundl Financial Technologies Inc clinicians retain the decision to prescribe compounded GLP-1s to patients.
All claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire and every 3 to 4 weeks thereafter. Results from compounded medications found on the Mars Labs platform may vary and be affected by an individual's adherence to the program and their clinician's recommendations. Compounded GLP-1s are prepared by state-licensed compounding pharmacies. Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and medical history.
We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. Mars Labs does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.
Individual results vary based on starting weight, program adherence, and other factors, and are not guaranteed. Medication prescriptions are at the discretion of licensed medical providers and may not be suitable for everyone. Weight management results depend on a healthy diet and regular exercise alongside any prescribed treatment. Consult a healthcare professional before using medication or starting any weight loss program.
Medication is included in the Mars Labs program. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss. The trademarks, service marks, trade names (Wegovy®, Ozempic®), and products displayed on this internet site are protected and belong to their respective owners. Medical treatment is provided by Bundl Financial Technologies Inc, an affiliated network of medical professional corporations and associations. No data, photos, claims or any other information is associated with results derived from clinical trials, studies or public information, and is always representative of Mars Labs patient experience.
Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies. No representation or warranty is made regarding the accuracy, completeness, or reliability of such content. Individuals appearing in advertisements may be actors or AI portraying doctors and are not licensed medical professionals.
Testimonials on the website are from Mars Labs patients. For patient privacy, images representing those testimonials may use models or AI.
© 2026 Mars Labs. All rights reserved.
Medical services provided by Bundl Financial Technologies Inc.